Dr. David Hava serves as Chief Scientific Officer and Head of Research and Development where he has responsibility for oversight of the company’s preclinical pipeline and clinical programs, including leadership of Synlogic’s collaborations with Roche and Ginkgo Bioworks. He joined Synlogic with 16 years of experience in the pharmaceutical industry leading platform and drug development programs.